1990-2017年全球其他肌肉骨骼疾病负担分析
该研究基于2017年全球疾病负担研究(GBD)的公开模型估计,描述1990-2017年其他肌肉骨骼疾病(RA、OA、腰背痛、颈痛和痛风未覆盖者)按年龄、性别和社会人口指数分布的时点患病率、死亡与伤残调整生命年(DALY)水平及趋势。全球2017年年龄标化时点患病率为4151.1/10万、死亡率为1.0/10万,分别上升3.4%和7.2%,年龄标化DALY率为380.2,上升3.4%。
要点
- 2017年全球其他MSK疾病年龄标化时点患病率为4151.1/10万,较1990年上升3.4%。
- 女性患病率高于男性,且随年龄增长,65-69岁组达峰后下降。
- 国家间差异明显,孟加拉国、印度和尼泊尔年龄标化患病率最高。
核心结论
- 其他肌肉骨骼疾病负担在全球范围内显著且持续增加,国家间差异明显。
- 需针对该大类中具体疾病的数据,以改进未来GBD肌肉骨骼估计。
研究设计与样本
- 基于GBD 2017研究的公开模型估计,提取1990-2017年195个国家和地区的计数及每10万人口年龄标化率。
主要发现
- 2017年全球年龄标化时点患病率为4151.1/10万,较1990年上升3.4%。
- 2017年全球年龄标化死亡率为1.0/10万,上升7.2%。
- 2017年全球年龄标化DALY率为380.2,上升3.4%。
- 女性时点患病率高于男性,且随年龄增长,2017年男女均在65-69岁组达峰后下降。
- 2017年年龄标化时点患病率最高的国家为孟加拉国、印度和尼泊尔;增幅最大的为罗马尼亚、克罗地亚和亚美尼亚。
临床怎么用
- 提示临床关注其他肌肉骨骼疾病在女性及65-69岁人群中的较高患病负担。
- 为国家层面资源配置和干预提供依据,但需具体疾病数据支持精准决策。
局限性
- 仅基于GBD 2017模型估计,缺乏该大类中具体疾病的详细数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the level and trends of point prevalence, deaths and disability-adjusted life years (DALYs) for other musculoskeletal (MSK) disorders, i.e. those not covered by specific estimates generated for RA, OA, low back pain, neck pain and gout, from 1990 to 2017 by age, sex and sociodemographic index. METHODS: Publicly available modelled estimates from the Global Burden of Disease (GBD) 2017 study were extracted and reported as counts and age-standardized rates per 100 000 population for 195 countries and territories between 1990 and 2017. RESULTS: Globally, the age-standardized point prevalence estimates and deaths rates of other MSK disorders in 2017 were 4151.1 and 1.0 per 100 000. This was an increase of 3.4% and 7.2%, respectively. The age-standardized DALY rate in 2017 was 380.2, an increase of 3.4%. The point prevalence estimate was higher among females and increased with age. This peaked in the 65-69 year age group for both females and males in 2017, followed by a decreasing trend for both sexes. At the national level, the highest age-standardized point prevalence estimates in 2017 were seen in Bangladesh, India and Nepal. The largest increases in age-standardized point prevalence estimates were observed in Romania, Croatia and Armenia. CONCLUSION: The burden of other MSK disorders is proven to be substantial and increasing worldwide, with a notable intercountry variation. Data pertaining to specific diseases within this overarching category are required for future GBD MSK estimates. This would enable policymakers to better allocate resources and provide interventions appropriately.
引用
- Safiri S, Kolahi AA, Cross M, et al. Global, regional, and national burden of other musculoskeletal disorders 1990-2017: results from the Global Burden of Disease Study 2017. Rheumatology (Oxford). 2021. PMID: 32840303. doi:10.1093/rheumatology/keaa315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。